within Pharmacolibrary.Drugs.ATC.C;

model C02AC06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.72,
    Cl             = 0.08833333333333333,
    adminDuration  = 600,
    adminMass      = 0.001,
    adminCount     = 1,
    Vd             = 0.049,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01983333333333333,
    Tlag           = 10.799999999999999
  );

  annotation(Documentation(
    info ="<html><body><p>Rilmenidine is a centrally acting antihypertensive agent of the imidazoline receptor agonist class. It is primarily used for the treatment of mild to moderate essential hypertension. It acts mainly through stimulation of imidazoline receptors in the brainstem, leading to a reduction of sympathetic outflow and subsequent decrease in blood pressure. Rilmenidine is approved and used in several countries, particularly in Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following single oral dose administration.</p><h4>References</h4><ol><li><p>Genissel, P, &amp; Bromet, N (1989). Pharmacokinetics of rilmenidine. <i>The American journal of medicine</i> 87(3C) 18S–23S. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(89)90500-7&quot;>10.1016/0002-9343(89)90500-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2782323/&quot;>https://pubmed.ncbi.nlm.nih.gov/2782323</a></p></li><li><p>Singlas, E, et al., &amp; Genissel, P (1988). Pharmacokinetics of rilmenidine. <i>The American journal of cardiology</i> 61(7) 54D–59D. DOI:<a href=&quot;https://doi.org/10.1016/0002-9149(88)90466-3&quot;>10.1016/0002-9149(88)90466-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2894159/&quot;>https://pubmed.ncbi.nlm.nih.gov/2894159</a></p></li><li><p>Genissel, P, et al., &amp; Albin, H (1988). Pharmacokinetics of rilmenidine in healthy subjects. <i>The American journal of cardiology</i> 61(7) 47D–53D. DOI:<a href=&quot;https://doi.org/10.1016/0002-9149(88)90465-1&quot;>10.1016/0002-9149(88)90465-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2894158/&quot;>https://pubmed.ncbi.nlm.nih.gov/2894158</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C02AC06;
